Proteome profiling of nasopharynx reveals pathophysiological signature of COVID-19 disease severity

An aberrant innate immune system caused by the beta coronavirus SARS-CoV-2 is a characteristic manifestation of severe coronavirus disease 2019 (COVID-19). Here, we performed proteome profiling of nasopharyngeal (NP) swabs from 273 hospitalized patients with mild and severe COVID-19 symptoms, includ...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv
Main Authors Ooi, Amanda, Esau, Luke E., Pugachev, Artyom, Groen, Arnoud, Mfarrej, Sara, Salunke, Rahul P., Subudhi, Amit K., Ben-Rached, Fathia, Alofi, Fadwa, Alsomali, Afrah, Alquthami, Khaled, Khogeer, Asim, Hashem, Anwar M., Almontashiri, Naif, Magistretti, Pierre J., Hala, Sharif, Pain, Arnab
Format Paper
LanguageEnglish
Published Cold Spring Harbor Laboratory 10.07.2023
Edition1.1
Subjects
Online AccessGet full text

Cover

Loading…
Abstract An aberrant innate immune system caused by the beta coronavirus SARS-CoV-2 is a characteristic manifestation of severe coronavirus disease 2019 (COVID-19). Here, we performed proteome profiling of nasopharyngeal (NP) swabs from 273 hospitalized patients with mild and severe COVID-19 symptoms, including non-survivors. We identified depletion in STAT1-mediated type I interferon response, retinol metabolism and NRF2 antioxidant system that are associated with disease severity in our patient demography. We found that the dysregulation of glucocorticoid signaling and renin-angiotensin-aldosterone system (RAAS) contribute to the pathophysiology of COVID-19 fatality. Hyperactivation of host innate immune system was observed in severe patients, marked by elevated proteins involved in neutrophil degranulation and platelet aggregation. Our study using high-throughput proteomics on the nasopharynx of COVID-19 patients provides additional evidence on the SARS-CoV-2-induced pathophysiological signatures of disease severity and fatality.
AbstractList An aberrant innate immune system caused by the beta coronavirus SARS-CoV-2 is a characteristic manifestation of severe coronavirus disease 2019 (COVID-19). Here, we performed proteome profiling of nasopharyngeal (NP) swabs from 273 hospitalized patients with mild and severe COVID-19 symptoms, including non-survivors. We identified depletion in STAT1-mediated type I interferon response, retinol metabolism and NRF2 antioxidant system that are associated with disease severity in our patient demography. We found that the dysregulation of glucocorticoid signaling and renin-angiotensin-aldosterone system (RAAS) contribute to the pathophysiology of COVID-19 fatality. Hyperactivation of host innate immune system was observed in severe patients, marked by elevated proteins involved in neutrophil degranulation and platelet aggregation. Our study using high-throughput proteomics on the nasopharynx of COVID-19 patients provides additional evidence on the SARS-CoV-2-induced pathophysiological signatures of disease severity and fatality.
Author Esau, Luke E.
Alsomali, Afrah
Pain, Arnab
Salunke, Rahul P.
Almontashiri, Naif
Ooi, Amanda
Magistretti, Pierre J.
Hala, Sharif
Subudhi, Amit K.
Ben-Rached, Fathia
Mfarrej, Sara
Hashem, Anwar M.
Alofi, Fadwa
Pugachev, Artyom
Alquthami, Khaled
Groen, Arnoud
Khogeer, Asim
Author_xml – sequence: 1
  givenname: Amanda
  orcidid: 0000-0001-8745-4336
  surname: Ooi
  fullname: Ooi, Amanda
  organization: Bioscience Program, Division of Biological and Environmental Sciences and Engineering, 4700 King Abdullah University of Science and Technology
– sequence: 2
  givenname: Luke E.
  surname: Esau
  fullname: Esau, Luke E.
  organization: Bioscience Program, Division of Biological and Environmental Sciences and Engineering, 4700 King Abdullah University of Science and Technology
– sequence: 3
  givenname: Artyom
  surname: Pugachev
  fullname: Pugachev, Artyom
  organization: ProteiQ Biosciences GmbH
– sequence: 4
  givenname: Arnoud
  surname: Groen
  fullname: Groen, Arnoud
  organization: ProteiQ Biosciences GmbH
– sequence: 5
  givenname: Sara
  surname: Mfarrej
  fullname: Mfarrej, Sara
  organization: Bioscience Program, Division of Biological and Environmental Sciences and Engineering, 4700 King Abdullah University of Science and Technology
– sequence: 6
  givenname: Rahul P.
  surname: Salunke
  fullname: Salunke, Rahul P.
  organization: Bioscience Program, Division of Biological and Environmental Sciences and Engineering, 4700 King Abdullah University of Science and Technology
– sequence: 7
  givenname: Amit K.
  surname: Subudhi
  fullname: Subudhi, Amit K.
  organization: Bioscience Program, Division of Biological and Environmental Sciences and Engineering, 4700 King Abdullah University of Science and Technology
– sequence: 8
  givenname: Fathia
  surname: Ben-Rached
  fullname: Ben-Rached, Fathia
  organization: Bioscience Program, Division of Biological and Environmental Sciences and Engineering, 4700 King Abdullah University of Science and Technology
– sequence: 9
  givenname: Fadwa
  surname: Alofi
  fullname: Alofi, Fadwa
  organization: Infectious Diseases Department, King Fahad Hospital
– sequence: 10
  givenname: Afrah
  surname: Alsomali
  fullname: Alsomali, Afrah
  organization: Infectious Diseases Department, King Abdullah Medical Complex
– sequence: 11
  givenname: Khaled
  surname: Alquthami
  fullname: Alquthami, Khaled
  organization: Infectious Diseases Medical Department, Al Noor Specialist Hospital
– sequence: 12
  givenname: Asim
  surname: Khogeer
  fullname: Khogeer, Asim
  organization: Plan and Research Department, General Directorate of Health Affairs Makkah Region
– sequence: 13
  givenname: Anwar M.
  surname: Hashem
  fullname: Hashem, Anwar M.
  organization: Department of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University
– sequence: 14
  givenname: Naif
  surname: Almontashiri
  fullname: Almontashiri, Naif
  organization: College of Applied Medical Sciences, Taibah University
– sequence: 15
  givenname: Pierre J.
  surname: Magistretti
  fullname: Magistretti, Pierre J.
  organization: KAUST Smart Health Initiative (KSHI), 4700 King Abdullah University of Science and Technology
– sequence: 16
  givenname: Sharif
  surname: Hala
  fullname: Hala, Sharif
  organization: King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs
– sequence: 17
  givenname: Arnab
  orcidid: 0000-0002-1755-2819
  surname: Pain
  fullname: Pain, Arnab
  email: arnab.pain@kaust.edu.sa
  organization: KAUST Smart Health Initiative (KSHI), 4700 King Abdullah University of Science and Technology
BookMark eNotkM9LwzAcxYMoOOf-AG85emn95lebHKXqHAzmYXgtSZZuka4pSR3rf2_HPD3eg8-D9x7QbRc6h9ATgZwQIC8UKMuhzEHlgksqxQ2a0ULRTFIQ92iR0g8AUFUQVvIZsl8xDC4cHe5jaHzruz0ODe50Cv1Bx7E74-hOTrcJ93o4TOGYfGjD3lvd4uT3nR5-o7sw1eZ79ZYRhXc-OZ0cThMY_TA-ortmKnCLf52j7cf7tvrM1pvlqnpdZ6YsRGYsMcqpRhpe6B2TgnMNIOyOC-m0oaCVIYwKTcBwy60myprJOmYpdVKxOXq-1hof4tmf6j764zShvlxSQ1mDqq-XsD-SnlpA
ContentType Paper
Copyright 2023, Posted by Cold Spring Harbor Laboratory
Copyright_xml – notice: 2023, Posted by Cold Spring Harbor Laboratory
DBID FX.
DOI 10.1101/2023.07.09.548285
DatabaseName bioRxiv
DatabaseTitleList
Database_xml – sequence: 1
  dbid: FX.
  name: bioRxiv
  url: https://www.biorxiv.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2692-8205
Edition 1.1
ExternalDocumentID 2023.07.09.548285v1
GroupedDBID 8FE
8FH
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
FX.
HCIFZ
LK8
M7P
NQS
PIMPY
PROAC
RHI
ID FETCH-LOGICAL-b765-bc1b9e9f8b46ad38544a005cd458eab20a9b1325a10b4c4ca19cb25ae3c22e893
IEDL.DBID FX.
IngestDate Tue Jan 07 18:59:08 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Keywords COVID-19 host nasopharynx/ innate immune system/ interferon signaling/ oxidative stress/ retinol metabolism
Language English
License The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b765-bc1b9e9f8b46ad38544a005cd458eab20a9b1325a10b4c4ca19cb25ae3c22e893
Notes Competing Interest Statement: The authors have declared no competing interest.
ORCID 0000-0002-1755-2819
0000-0001-8745-4336
OpenAccessLink https://www.biorxiv.org/content/10.1101/2023.07.09.548285
PageCount 51
ParticipantIDs biorxiv_primary_2023_07_09_548285
PublicationCentury 2000
PublicationDate 20230710
PublicationDateYYYYMMDD 2023-07-10
PublicationDate_xml – month: 7
  year: 2023
  text: 20230710
  day: 10
PublicationDecade 2020
PublicationTitle bioRxiv
PublicationYear 2023
Publisher Cold Spring Harbor Laboratory
Publisher_xml – name: Cold Spring Harbor Laboratory
References Gao, Li, Han, Li, Wu, Xu, Zhu, Liu, Wang, Wang (2023.07.09.548285v1.40) 2020; 92
Pan, Hu, Shi, Cai, Li, Zou, Ji (2023.07.09.548285v1.109) 2013; 8
Alam, Czajkowsky (2023.07.09.548285v1.1) 2021
Zhou, Zhou, Pache, Chang, Khodabakhshi, Tanaseichuk, Benner, Chanda (2023.07.09.548285v1.163) 2019; 10
Qin, Zhou, Hu, Zhang, Yang, Tao, Xie, Ma, Shang, Wang (2023.07.09.548285v1.116) 2020; 71
Ronit, Berg, Bay, Haugaard, Ahlstrom, Burgdorf, Ullum, Rorvig, Tjelle, Foss (2023.07.09.548285v1.121) 2021; 147
Wu, Hu, Zhang, Ren, Yu, Zhou (2023.07.09.548285v1.152) 2020; 24
Klein, Flanagan (2023.07.09.548285v1.68) 2016; 16
Arunachalam, Wimmers, Mok, Perera, Scott, Hagan, Sigal, Feng, Bristow, Tak-Yin Tsang (2023.07.09.548285v1.6) 2020; 369
Rooney, Oshida, Vasani, Vallanat, Ryan, Chorley, Wang, Bell, Wu, Aleksunes (2023.07.09.548285v1.122) 2018; 13
Webb, Peltan, Jensen, Hoda, Hunter, Silver, Starr, Buckel, Grisel, Hummel (2023.07.09.548285v1.150) 2020; 2
Cooper, Boyle, Jefferson, Heslop, Mohan, Mohanraj, Sidow, Tan, Hill, Woolard (2023.07.09.548285v1.25) 2021; 22
Matsuyama, Kubli, Yoshinaga, Pfeffer, Mak (2023.07.09.548285v1.93) 2020; 27
Casadevall, Pirofski (2023.07.09.548285v1.20) 2020; 117
Pichlmair, Schulz, Tan, Naslund, Liljestrom, Weber, Sousa (2023.07.09.548285v1.112) 2006; 314
Guarda, Braun, Staehli, Tardivel, Mattmann, Forster, Farlik, Decker, Du Pasquier, Romero (2023.07.09.548285v1.48) 2011; 34
Thimmulappa, Lee, Rangasamy, Reddy, Yamamoto, Kensler, Biswal (2023.07.09.548285v1.140) 2006; 116
Le Page, Genin, Baines, Hiscott (2023.07.09.548285v1.77) 2000; 2
Zheng, Ma, Zhang, Xie (2023.07.09.548285v1.162) 2020; 17
Huang, Wang, Li, Ren, Zhao, Hu, Zhang, Fan, Xu, Gu (2023.07.09.548285v1.58) 2020; 395
Patel, Rauf, Khan, Abu-Izneid (2023.07.09.548285v1.111) 2017; 94
Zhang, Xing, Hensley, Chang, Liao, Abu-Amer, Sandell (2023.07.09.548285v1.161) 2010; 62
Gaertner, Massberg (2023.07.09.548285v1.37) 2016; 28
Ponti, Maccaferri, Ruini, Tomasi, Ozben (2023.07.09.548285v1.114) 2020; 57
Henry, Benoit, Lippi, Benoit (2023.07.09.548285v1.55) 2020; 63
Teuwen, Geldhof, Pasut, Carmeliet (2023.07.09.548285v1.139) 2020; 20
Asano, Boisson, Onodi, Matuozzo, Moncada-Velez, Maglorius Renkilaraj, Zhang, Meertens, Bolze, Materna (2023.07.09.548285v1.7) 2021; 6
Rincon-Arevalo, Aue, Ritter, Szelinski, Khadzhynov, Zickler, Stefanski, Lino, Korper, Eckardt (2023.07.09.548285v1.119) 2022; 52
Yang, Chu, Hou, Chai, Shuai, Lee, Zhang, Wang, Hu, Huang (2023.07.09.548285v1.154) 2020; 222
Dorward, Russell, Um, Elshani, Armstrong, Penrice-Randal, Millar, Lerpiniere, Tagliavini, Hartley (2023.07.09.548285v1.32) 2021; 203
Muri, Kopf (2023.07.09.548285v1.102) 2021; 21
Group, Horby, Lim, Emberson, Mafham, Bell, Linsell, Staplin, Brightling, Ustianowski (2023.07.09.548285v1.46) 2021; 384
Lu, Wang, Sakthivel, Whitaker, Murray, Kamili, Lynch, Malapati, Burke, Harcourt (2023.07.09.548285v1.87) 2020; 26
Itoh, Ishii, Wakabayashi, Yamamoto (2023.07.09.548285v1.60) 1999; 31
Liu, Liu, Xiang, Pu, Xiong, Li, Zhang, Tan, Xu, Song (2023.07.09.548285v1.84) 2020a; 18
Zhang, Bastard, Liu, Le Pen, Moncada-Velez, Chen, Ogishi, Sabli, Hodeib, Korol (2023.07.09.548285v1.160) 2020c; 370
Meizlish, Pine, Bishai, Goshua, Nadelmann, Simonov, Chang, Zhang, Shallow, Bahel (2023.07.09.548285v1.95) 2021; 5
Bizzotto, Sanchis, Abbate, Lage-Vickers, Lavignolle, Toro, Olszevicki, Sabater, Cascardo, Vazquez (2023.07.09.548285v1.14) 2020; 23
Alwan, Burgess, Ashworth, Beale, Bhadelia, Bogaert, Dowd, Eckerle, Goldman, Greenhalgh (2023.07.09.548285v1.2) 2020; 396
Mogensen (2023.07.09.548285v1.99) 2009; 22
Naqvi, Fatima, Mohammad, Fatima, Singh, Singh, Atif, Hariprasad, Hasan, Hassan (2023.07.09.548285v1.103) 2020; 1866
Chattha, Kandasamy, Vlasova, Saif (2023.07.09.548285v1.21) 2013; 8
Griendling, Minieri, Ollerenshaw, Alexander (2023.07.09.548285v1.45) 1994; 74
Mascolo, Scavone, Rafaniello, De Angelis, Urbanek, di Mauro, Cappetta, Berrino, Rossi, Capuano (2023.07.09.548285v1.91) 2021; 12
Mu, Fang, Yang, Shu, Wang, Huang, Jin, Deng, Qiu, Zhou (2023.07.09.548285v1.100) 2020; 6
Messner, Demichev, Wendisch, Michalick, White, Freiwald, Textoris-Taube, Vernardis, Egger, Kreidl (2023.07.09.548285v1.96) 2020; 11
Raghunath, Sundarraj, Nagarajan, Arfuso, Bian, Kumar, Sethi, Perumal (2023.07.09.548285v1.117) 2018; 17
Tan, Liu, Zhou, Deng, Li, Liang, Shi (2023.07.09.548285v1.136) 2020; 160
Kobayashi, Suzuki, Funayama, Nagashima, Hayashi, Sekine, Tanaka, Moriguchi, Motohashi, Nakayama (2023.07.09.548285v1.70) 2016; 7
Bunders, Altfeld (2023.07.09.548285v1.18) 2020; 53
Zaid, Dore, Dubuc, Archambault, Flamand, Laviolette, Flamand, Boilard, Flamand (2023.07.09.548285v1.156) 2021; 148
Mun, Vanderboom, Madugundu, Garapati, Chavan, Peterson, Saraswat, Pandey (2023.07.09.548285v1.101) 2021; 20
Leng, Li, Li, Mou, Liu, Ma, Zhang, Li, Cao, Zhong (2023.07.09.548285v1.81) 2021; 6
Chow, Gale, Loo (2023.07.09.548285v1.23) 2018; 36
Tong, Wang, Liao, Xiao, Qu, Wu, Zhu, Tai, Huang, Wang (2023.07.09.548285v1.141) 2022; 13
Hughes, Moggridge, Muller, Sorensen, Morin, Krijgsveld (2023.07.09.548285v1.59) 2019; 14
Flacco, Acuti Martellucci, Bravi, Parruti, Cappadona, Mascitelli, Manfredini, Mantovani, Manzoli (2023.07.09.548285v1.35) 2020; 106
Klok, Kruip, van der Meer, Arbous, Gommers, Kant, Kaptein, van Paassen, Stals, Huisman (2023.07.09.548285v1.69) 2020; 191
Davey, McAuley, O’Kane (2023.07.09.548285v1.27) 2011; 38
Kumar, Guruparan, Siddiqi, Sheth, Jacyna, Naghibi, Vrentzou (2023.07.09.548285v1.74) 2020; 6
Gai, Taki, Kato, Nagaishi (2023.07.09.548285v1.38) 2003; 142
Rosenbaum (2023.07.09.548285v1.123) 2020; 382
Bousquet, Cristol, Czarlewski, Anto, Martineau, Haahtela, Fonseca, Iaccarino, Blain, Fiocchi (2023.07.09.548285v1.17) 2020; 10
Gack, Shin, Joo, Urano, Liang, Sun, Takeuchi, Akira, Chen, Inoue (2023.07.09.548285v1.36) 2007; 446
Gheblawi, Wang, Viveiros, Nguyen, Zhong, Turner, Raizada, Grant, Oudit (2023.07.09.548285v1.41) 2020; 126
Takahashi, Ellingson, Wong, Israelow, Lucas, Klein, Silva, Mao, Oh, Tokuyama (2023.07.09.548285v1.135) 2020; 588
Laforge, Elbim, Frere, Hemadi, Massaad, Nuss, Benoliel, Becker (2023.07.09.548285v1.76) 2020; 20
Del Valle, Kim-Schulze, Huang, Beckmann, Nirenberg, Wang, Lavin, Swartz, Madduri, Stock (2023.07.09.548285v1.28) 2020; 26
Onoguchi, Yoneyama, Fujita (2023.07.09.548285v1.106) 2011; 31
Atkinson (2023.07.09.548285v1.8) 2003; 113
Blanco-Melo, Nilsson-Payant, Liu, Uhl, Hoagland, Moller, Jordan, Oishi, Panis, Sachs (2023.07.09.548285v1.15) 2020; 181
Cain, Cidlowski (2023.07.09.548285v1.19) 2020; 20
Kuleshov, Jones, Rouillard, Fernandez, Duan, Wang, Koplev, Jenkins, Jagodnik, Lachmann (2023.07.09.548285v1.73) 2016; 44
Bhargava, Lahaye, Manel (2023.07.09.548285v1.13) 2018; 40
Chen, Lin, Gao, Li, Zhang, Xing, Deng, Yao, Tsun, Li (2023.07.09.548285v1.22) 2011; 11
Sarohan, Akelma, Arac, Aslan, Cen (2023.07.09.548285v1.127) 2022; 43
Paludan, Mogensen (2023.07.09.548285v1.108) 2022; 7
Vollmy, van den Toorn, Zenezini Chiozzi, Zucchetti, Papi, Volta, Marracino, Vieceli Dalla Sega, Fortini, Demichev (2023.07.09.548285v1.148) 2021; 4
Barnes, Adrover, Baxter-Stoltzfus, Borczuk, Cools-Lartigue, Crawford, Dassler-Plenker, Guerci, Huynh, Knight (2023.07.09.548285v1.10) 2020; 217
Baggiolini, Walz, Kunkel (2023.07.09.548285v1.9) 1989; 84
Hadjadj, Yatim, Barnabei, Corneau, Boussier, Smith, Pere, Charbit, Bondet, Chenevier-Gobeaux (2023.07.09.548285v1.49) 2020; 369
Mi, Ebert, Muruganujan, Mills, Albou, Mushayamaha, Thomas (2023.07.09.548285v1.97) 2021; 49
Pinero, Bravo, Queralt-Rosinach, Gutierrez-Sacristan, Deu-Pons, Centeno, Garcia-Garcia, Sanz, Furlong (2023.07.09.548285v1.113) 2017; 45
Vaduganathan, Vardeny, Michel, McMurray, Pfeffer, Solomon (2023.07.09.548285v1.144) 2020; 382
Sarohan, Kizil, Inkaya, Mahmud, Akram, Cen (2023.07.09.548285v1.128) 2021; 87
Shen, Yi, Sun, Bi, Du, Zhang, Quan, Zhang, Sun, Qian (2023.07.09.548285v1.132) 2020; 182
Masood, Yameen, Ashraf, Shahid, Mahmood, Nasir, Nasir, Jamil, Ghanchi, Khanum (2023.07.09.548285v1.92) 2021; 11
Manne, Denorme, Middleton, Portier, Rowley, Stubben, Petrey, Tolley, Guo, Cody (2023.07.09.548285v1.90) 2020; 136
Della-Morte, Pacifici, Ricordi, Massoud, Rovella, Proietti, Iozzo, Lauro, Bernardini, Bonassi (2023.07.09.548285v1.30) 2021; 12
Grant, Morales-Nebreda, Markov, Swaminathan, Querrey, Guzman, Abbott, Donnelly, Donayre, Goldberg (2023.07.09.548285v1.44) 2021; 590
Lee, Shin (2023.07.09.548285v1.79) 2020; 20
Hidalgo, Chang, Jang, Peired, Chiang, Frenette (2023.07.09.548285v1.56) 2009; 15
Schulte-Schrepping, Reusch, Paclik, Bassler, Schlickeiser, Zhang, Kramer, Krammer, Brumhard, Bonaguro (2023.07.09.548285v1.131) 2020; 182
Dalskov, Mohlenberg, Thyrsted, Blay-Cadanet, Poulsen, Folkersen, Skaarup, Olagnier, Reinert, Enghild (2023.07.09.548285v1.26) 2020; 21
Rysz, Al-Saadi, Sjostrom, Farm, Campoccia Jalde, Platten, Eriksson, Klein, Vargas-Paris, Nyren (2023.07.09.548285v1.125) 2021; 12
Pal (2023.07.09.548285v1.107) 2020; 68
Annane, Pastores, Rochwerg, Arlt, Balk, Beishuizen, Briegel, Carcillo, Christ-Crain, Cooper (2023.07.09.548285v1.5) 2017b; 45
Rusinova, Forster, Yu, Kannan, Masse, Cumming, Chapman, Hertzog (2023.07.09.548285v1.124) 2013; 41
Middleton, He, Denorme, Campbell, Ng, Salvatore, Mostyka, Baxter-Stoltzfus, Borczuk, Loda (2023.07.09.548285v1.98) 2020; 136
Tepasse, Vollenberg, Fobker, Kabar, Schmidt, Meier, Nowacki, Husing-Kabar (2023.07.09.548285v1.138) 2021; 13
Jung, Choi, You, Kim (2023.07.09.548285v1.62) 2020; 71
Wilk, Rustagi, Zhao, Roque, Martinez-Colon, McKechnie, Ivison, Ranganath, Vergara, Hollis (2023.07.09.548285v1.151) 2020; 26
Henry, Benoit, Berger, Pulvino, Lavie, Lippi, Benoit (2023.07.09.548285v1.54) 2021; 93
Baumann, Gauldie (2023.07.09.548285v1.12) 1990; 7
Ye, Chen, Li, Lan, Ji, Hou, Zhang, Zeng, Wang, Xu (2023.07.09.548285v1.155) 2020; 21
Andolfo, Russo, Lasorsa, Cantalupo, Rosato, BonFigurelio, Frisso, Abete, Cassese, Servillo (2023.07.09.548285v1.3) 2021; 24
Elias, Laurence, Davidson, Stephens, Kanno, Shevach, O’Shea (2023.07.09.548285v1.33) 2008; 111
Gori Savellini, Anichini, Gandolfo, Cusi (2023.07.09.548285v1.43) 2021; 13
Trasino (2023
References_xml – volume: 17
  start-page: 259
  year: 2020
  end-page: 260
  ident: 2023.07.09.548285v1.162
  article-title: COVID-19 and the cardiovascular system
  publication-title: Nat Rev Cardiol
– volume: 10
  start-page: 1523
  year: 2019
  ident: 2023.07.09.548285v1.163
  article-title: Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
  publication-title: Nat Commun
– volume: 11
  start-page: 373
  year: 2010
  end-page: 384
  ident: 2023.07.09.548285v1.65
  article-title: The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
  publication-title: Nat Immunol
– volume: 31
  start-page: 27
  year: 2011
  end-page: 31
  ident: 2023.07.09.548285v1.106
  article-title: Retinoic acid-inducible gene-I-like receptors
  publication-title: J Interferon Cytokine Res
– volume: 57
  start-page: 389
  year: 2020
  end-page: 399
  ident: 2023.07.09.548285v1.114
  article-title: Biomarkers associated with COVID-19 disease progression
  publication-title: Crit Rev Clin Lab Sci
– volume: 52
  start-page: 138
  year: 2022
  end-page: 148
  ident: 2023.07.09.548285v1.119
  article-title: Altered increase in STAT1 expression and phosphorylation in severe COVID-19
  publication-title: Eur J Immunol
– volume: 12
  start-page: 667254
  year: 2021
  ident: 2023.07.09.548285v1.91
  article-title: The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
  publication-title: Front Pharmacol
– volume: 45
  start-page: D833
  year: 2017
  end-page: D839
  ident: 2023.07.09.548285v1.113
  article-title: DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
  publication-title: Nucleic Acids Res
– volume: 6
  start-page: 16826
  year: 2021
  end-page: 16836
  ident: 2023.07.09.548285v1.153
  article-title: SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics
  publication-title: ACS Omega
– volume: 44
  start-page: W90
  year: 2016
  end-page: 97
  ident: 2023.07.09.548285v1.73
  article-title: Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
  publication-title: Nucleic Acids Res
– volume: 27
  start-page: 3209
  year: 2020
  end-page: 3225
  ident: 2023.07.09.548285v1.93
  article-title: An aberrant STAT pathway is central to COVID-19
  publication-title: Cell Death Differ
– volume: 10
  start-page: 58
  year: 2020
  ident: 2023.07.09.548285v1.17
  article-title: Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies
  publication-title: Clin Transl Allergy
– volume: 36
  start-page: 667
  year: 2018
  end-page: 694
  ident: 2023.07.09.548285v1.23
  article-title: RIG-I and Other RNA Sensors in Antiviral Immunity
  publication-title: Annu Rev Immunol
– volume: 26
  start-page: 1070
  year: 2020
  end-page: 1076
  ident: 2023.07.09.548285v1.151
  article-title: A single-cell atlas of the peripheral immune response in patients with severe COVID-19
  publication-title: Nat Med
– volume: 17
  start-page: 297
  year: 2018
  end-page: 314
  ident: 2023.07.09.548285v1.117
  article-title: Antioxidant response elements: Discovery, classes, regulation and potential applications
  publication-title: Redox Biol
– volume: 111
  start-page: 1013
  year: 2008
  end-page: 1020
  ident: 2023.07.09.548285v1.33
  article-title: Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway
  publication-title: Blood
– volume: 62
  start-page: 1993
  year: 2010
  end-page: 2003
  ident: 2023.07.09.548285v1.161
  article-title: Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization
  publication-title: Arthritis Rheum
– volume: 113
  start-page: 22
  year: 2003
  end-page: 23
  ident: 2023.07.09.548285v1.8
  article-title: The HSJ interview: Dr Sue Atkinson. Double impact. Interview by Helen Mooney
  publication-title: Health Serv J
– volume: 1143
  start-page: 1
  year: 2008
  end-page: 20
  ident: 2023.07.09.548285v1.64
  article-title: Toll-like receptor and RIG-I-like receptor signaling
  publication-title: Ann N Y Acad Sci
– volume: 136
  start-page: 1330
  year: 2020
  end-page: 1341
  ident: 2023.07.09.548285v1.57
  article-title: Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
  publication-title: Blood
– volume: 12
  start-page: 2417
  year: 2021
  ident: 2023.07.09.548285v1.125
  article-title: COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
  publication-title: Nat Commun
– volume: 217
  year: 2020
  ident: 2023.07.09.548285v1.10
  article-title: Targeting potential drivers of COVID-19: Neutrophil extracellular traps
  publication-title: J Exp Med
– volume: 41
  start-page: 1100
  year: 2020
  end-page: 1115
  ident: 2023.07.09.548285v1.51
  article-title: Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
  publication-title: Trends Immunol
– volume: 20
  start-page: 448
  year: 2020
  ident: 2023.07.09.548285v1.139
  article-title: Author Correction: COVID-19: the vasculature unleashed
  publication-title: Nat Rev Immunol
– volume: 446
  start-page: 916
  year: 2007
  end-page: 920
  ident: 2023.07.09.548285v1.36
  article-title: TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity
  publication-title: Nature
– volume: 80
  start-page: 646
  year: 2020
  end-page: 655
  ident: 2023.07.09.548285v1.83
  article-title: Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis
  publication-title: J Infect
– volume: 13
  start-page: e0148522
  year: 2022
  ident: 2023.07.09.548285v1.141
  article-title: A Retinol Derivative Inhibits SARS-CoV-2 Infection by Interrupting Spike-Mediated Cellular Entry
  publication-title: mBio
– volume: 182
  start-page: 1419
  year: 2020
  ident: 2023.07.09.548285v1.131
  article-title: Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
  publication-title: Cell
– volume: 36
  start-page: 101655
  year: 2020
  ident: 2023.07.09.548285v1.147
  article-title: Nox2 activation in Covid-19
  publication-title: Redox Biol
– volume: 11
  start-page: 4938
  year: 2020
  ident: 2023.07.09.548285v1.105
  article-title: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
  publication-title: Nat Commun
– volume: 8
  start-page: 81
  year: 2017
  ident: 2023.07.09.548285v1.29
  article-title: Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview
  publication-title: Front Immunol
– volume: 13
  year: 2021
  ident: 2023.07.09.548285v1.138
  article-title: Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis
  publication-title: Nutrients
– volume: 31
  start-page: 319
  year: 1999
  end-page: 324
  ident: 2023.07.09.548285v1.60
  article-title: Regulatory mechanisms of cellular response to oxidative stress
  publication-title: Free Radic Res
– volume: 2
  start-page: e754
  year: 2020
  end-page: e763
  ident: 2023.07.09.548285v1.150
  article-title: Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
  publication-title: Lancet Rheumatol
– volume: 38
  start-page: 959
  year: 2011
  end-page: 970
  ident: 2023.07.09.548285v1.27
  article-title: Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair
  publication-title: Eur Respir J
– volume: 20
  start-page: 585
  year: 2020
  end-page: 586
  ident: 2023.07.09.548285v1.79
  article-title: The type I interferon response in COVID-19: implications for treatment
  publication-title: Nat Rev Immunol
– volume: 58
  start-page: 102925
  year: 2020
  ident: 2023.07.09.548285v1.82
  article-title: Vascular occlusion by neutrophil extracellular traps in COVID-19
  publication-title: EBioMedicine
– volume: 18
  start-page: 206
  year: 2020a
  ident: 2023.07.09.548285v1.84
  article-title: Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage
  publication-title: J Transl Med
– volume: 6
  year: 2021
  ident: 2023.07.09.548285v1.7
  article-title: X-linked recessive TLR7 deficiency in ∼1% of men under 60 years old with life-threatening COVID-19
  publication-title: Sci Immunol
– volume: 314
  start-page: 997
  year: 2006
  end-page: 1001
  ident: 2023.07.09.548285v1.112
  article-title: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
  publication-title: Science
– volume: 111
  start-page: E3432
  year: 2014
  end-page: 3440
  ident: 2023.07.09.548285v1.86
  article-title: Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions
  publication-title: Proc Natl Acad Sci U S A
– volume: 20
  start-page: 587
  year: 2020
  end-page: 588
  ident: 2023.07.09.548285v1.19
  article-title: After 62 years of regulating immunity, dexamethasone meets COVID-19
  publication-title: Nat Rev Immunol
– volume: 32
  start-page: 513
  year: 2014
  end-page: 545
  ident: 2023.07.09.548285v1.129
  article-title: Interferon-stimulated genes: a complex web of host defenses
  publication-title: Annu Rev Immunol
– volume: 15
  start-page: 384
  year: 2009
  end-page: 391
  ident: 2023.07.09.548285v1.56
  article-title: Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury
  publication-title: Nat Med
– volume: 63
  start-page: 702
  year: 2020
  end-page: 703
  ident: 2023.07.09.548285v1.55
  article-title: Letter to the Editor - Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): A preliminary report
  publication-title: Prog Cardiovasc Dis
– volume: 92
  start-page: 791
  year: 2020
  end-page: 796
  ident: 2023.07.09.548285v1.40
  article-title: Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
  publication-title: J Med Virol
– volume: 8
  start-page: e21
  year: 2020
  ident: 2023.07.09.548285v1.34
  article-title: Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
  publication-title: Lancet Respir Med
– year: 2021
  ident: 2023.07.09.548285v1.126
  article-title: Primary Adrenal Insufficiency After COVID-19 Infection
  publication-title: AACE Clin Case Rep
– volume: 20
  start-page: 4165
  year: 2021
  end-page: 4175
  ident: 2023.07.09.548285v1.101
  article-title: DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients
  publication-title: J Proteome Res
– volume: 4
  year: 2021
  ident: 2023.07.09.548285v1.148
  article-title: A serum proteome signature to predict mortality in severe COVID-19 patients
  publication-title: Life Sci Alliance
– volume: 41
  start-page: 1801
  year: 2020
  end-page: 1803
  ident: 2023.07.09.548285v1.75
  article-title: SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
  publication-title: Eur Heart J
– volume: 50
  start-page: 119
  year: 2021
  end-page: 127
  ident: 2023.07.09.548285v1.157
  article-title: Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?
  publication-title: Curr Opin Virol
– volume: 2008
  start-page: 416910
  year: 2008
  ident: 2023.07.09.548285v1.66
  article-title: Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids
  publication-title: Clin Dev Immunol
– volume: 28
  start-page: 561
  year: 2016
  end-page: 569
  ident: 2023.07.09.548285v1.37
  article-title: Blood coagulation in immunothrombosis-At the frontline of intravascular immunity
  publication-title: Semin Immunol
– volume: 34
  start-page: 213
  year: 2011
  end-page: 223
  ident: 2023.07.09.548285v1.48
  article-title: Type I interferon inhibits interleukin-1 production and inflammasome activation
  publication-title: Immunity
– volume: 102
  start-page: 1313
  year: 2007
  end-page: 1322
  ident: 2023.07.09.548285v1.78
  article-title: Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness
  publication-title: J Appl Physiol
– volume: 84
  start-page: 1045
  year: 1989
  end-page: 1049
  ident: 2023.07.09.548285v1.9
  article-title: Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils
  publication-title: J Clin Invest
– volume: 11
  start-page: 11
  year: 2020
  end-page: 24
  ident: 2023.07.09.548285v1.96
  article-title: Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
  publication-title: Cell Syst
– volume: 21
  start-page: 363
  year: 2021
  end-page: 381
  ident: 2023.07.09.548285v1.102
  article-title: Redox regulation of immunometabolism
  publication-title: Nat Rev Immunol
– volume: 26
  year: 2020
  ident: 2023.07.09.548285v1.87
  article-title: US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2
  publication-title: Emerg Infect Dis
– year: 2021
  ident: 2023.07.09.548285v1.1
  article-title: SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities
  publication-title: Cytokine Growth Factor Rev
– volume: 383
  start-page: 1483
  year: 2020
  end-page: 1488
  ident: 2023.07.09.548285v1.16
  article-title: Covid-19 - Implications for the Health Care System
  publication-title: N Engl J Med
– volume: 142
  start-page: 414
  year: 2003
  end-page: 420
  ident: 2023.07.09.548285v1.38
  article-title: Regulation of hemoglobin affinity for oxygen by carbonic anhydrase
  publication-title: J Lab Clin Med
– volume: 5
  start-page: 1164
  year: 2021
  end-page: 1177
  ident: 2023.07.09.548285v1.95
  article-title: A neutrophil activation signature predicts critical illness and mortality in COVID-19
  publication-title: Blood Adv
– volume: 94
  start-page: 317
  year: 2017
  end-page: 325
  ident: 2023.07.09.548285v1.111
  article-title: Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies
  publication-title: Biomed Pharmacother
– volume: 40
  start-page: 59
  year: 2018
  end-page: 67
  ident: 2023.07.09.548285v1.13
  article-title: Let me in: Control of HIV nuclear entry at the nuclear envelope
  publication-title: Cytokine Growth Factor Rev
– volume: 71
  start-page: 762
  year: 2020
  end-page: 768
  ident: 2023.07.09.548285v1.116
  article-title: Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
  publication-title: Clin Infect Dis
– volume: 42
  start-page: 312
  year: 2021
  end-page: 322
  ident: 2023.07.09.548285v1.67
  article-title: Dual Nature of Type I Interferons in SARS-CoV-2-Induced Inflammation
  publication-title: Trends Immunol
– volume: 382
  start-page: 1653
  year: 2020
  end-page: 1659
  ident: 2023.07.09.548285v1.144
  article-title: Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
  publication-title: N Engl J Med
– volume: 160
  start-page: 261
  year: 2020
  end-page: 268
  ident: 2023.07.09.548285v1.136
  article-title: Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China
  publication-title: Immunology
– volume: 22
  start-page: 240
  year: 2009
  end-page: 273
  ident: 2023.07.09.548285v1.99
  article-title: Pathogen recognition and inflammatory signaling in innate immune defenses
  publication-title: Clin Microbiol Rev
– volume: 2
  start-page: 374
  year: 2000
  end-page: 386
  ident: 2023.07.09.548285v1.77
  article-title: Interferon activation and innate immunity
  publication-title: Rev Immunogenet
– volume: 148
  start-page: 368
  year: 2021
  end-page: 380
  ident: 2023.07.09.548285v1.156
  article-title: Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19
  publication-title: J Allergy Clin Immunol
– volume: 24
  start-page: 102322
  year: 2021
  ident: 2023.07.09.548285v1.3
  article-title: Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19
  publication-title: iScience
– volume: 9
  year: 2020
  ident: 2023.07.09.548285v1.110
  article-title: Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils’ but Impaired Monocytes’ and Dendritic Cells’ Responsiveness
  publication-title: Cells
– volume: 191
  start-page: 148
  year: 2020
  end-page: 150
  ident: 2023.07.09.548285v1.69
  article-title: Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
  publication-title: Thromb Res
– volume: 586
  start-page: 113
  year: 2020
  end-page: 119
  ident: 2023.07.09.548285v1.120
  article-title: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
  publication-title: Nature
– volume: 203
  start-page: 192
  year: 2021
  end-page: 201
  ident: 2023.07.09.548285v1.32
  article-title: Tissue-Specific Immunopathology in Fatal COVID-19
  publication-title: Am J Respir Crit Care Med
– volume: 7
  start-page: 147
  year: 1990
  end-page: 159
  ident: 2023.07.09.548285v1.12
  article-title: Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation
  publication-title: Mol Biol Med
– volume: 117
  start-page: 30009
  year: 2020
  end-page: 30011
  ident: 2023.07.09.548285v1.20
  article-title: In fatal COVID-19, the immune response can control the virus but kill the patient
  publication-title: Proc Natl Acad Sci U S A
– volume: 23
  start-page: 101585
  year: 2020
  ident: 2023.07.09.548285v1.14
  article-title: SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients
  publication-title: iScience
– volume: 382
  start-page: 2462
  year: 2020
  end-page: 2464
  ident: 2023.07.09.548285v1.61
  article-title: Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19
  publication-title: N Engl J Med
– volume: 590
  start-page: 635
  year: 2021
  end-page: 641
  ident: 2023.07.09.548285v1.44
  article-title: Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
  publication-title: Nature
– volume: 181
  start-page: 1036
  year: 2020
  end-page: 1045
  ident: 2023.07.09.548285v1.15
  article-title: Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
  publication-title: Cell
– volume: 81
  start-page: e41
  year: 2020
  end-page: e43
  ident: 2023.07.09.548285v1.143
  article-title: Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure
  publication-title: J Infect
– volume: 126
  start-page: 1456
  year: 2020
  end-page: 1474
  ident: 2023.07.09.548285v1.41
  article-title: Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2
  publication-title: Circ Res
– volume: 116
  start-page: 984
  year: 2006
  end-page: 995
  ident: 2023.07.09.548285v1.140
  article-title: Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
  publication-title: J Clin Invest
– volume: 12
  start-page: e7343
  year: 2020
  ident: 2023.07.09.548285v1.133
  article-title: Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19)
  publication-title: Cureus
– volume: 396
  start-page: e71
  year: 2020
  end-page: e72
  ident: 2023.07.09.548285v1.2
  article-title: Scientific consensus on the COVID-19 pandemic: we need to act now
  publication-title: Lancet
– volume: 20
  start-page: 579
  year: 2020
  ident: 2023.07.09.548285v1.76
  article-title: Author Correction: Tissue damage from neutrophil-induced oxidative stress in COVID-19
  publication-title: Nat Rev Immunol
– volume: 370
  year: 2020
  ident: 2023.07.09.548285v1.11
  article-title: Autoantibodies against type I IFNs in patients with life-threatening COVID-19
  publication-title: Science
– volume: 13
  year: 2021
  ident: 2023.07.09.548285v1.43
  article-title: SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity
  publication-title: Viruses
– volume: 41
  start-page: D1040
  year: 2013
  end-page: 1046
  ident: 2023.07.09.548285v1.124
  article-title: Interferome v2.0: an updated database of annotated interferon-regulated genes
  publication-title: Nucleic Acids Res
– volume: 370
  year: 2020c
  ident: 2023.07.09.548285v1.160
  article-title: Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
  publication-title: Science
– volume: 382
  start-page: 2431
  year: 2020
  end-page: 2440
  ident: 2023.07.09.548285v1.89
  article-title: Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
  publication-title: N Engl J Med
– volume: 74
  start-page: 1141
  year: 1994
  end-page: 1148
  ident: 2023.07.09.548285v1.45
  article-title: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
  publication-title: Circ Res
– volume: 14
  start-page: 134
  year: 2020
  ident: 2023.07.09.548285v1.53
  article-title: Adrenal insufficiency in coronavirus disease 2019: a case report
  publication-title: J Med Case Rep
– volume: 588
  start-page: 315
  year: 2020
  end-page: 320
  ident: 2023.07.09.548285v1.135
  article-title: Sex differences in immune responses that underlie COVID-19 disease outcomes
  publication-title: Nature
– volume: 26
  start-page: 1636
  year: 2020
  end-page: 1643
  ident: 2023.07.09.548285v1.28
  article-title: An inflammatory cytokine signature predicts COVID-19 severity and survival
  publication-title: Nat Med
– volume: 346
  start-page: 1234
  year: 2014
  end-page: 1238
  ident: 2023.07.09.548285v1.134
  article-title: Neutrophils scan for activated platelets to initiate inflammation
  publication-title: Science
– volume: 16
  start-page: 626
  year: 2016
  end-page: 638
  ident: 2023.07.09.548285v1.68
  article-title: Sex differences in immune responses
  publication-title: Nat Rev Immunol
– volume: 43
  start-page: 85
  year: 2022
  end-page: 94
  ident: 2023.07.09.548285v1.127
  article-title: Retinol Depletion in COVID-19
  publication-title: Clin Nutr Open Sci
– volume: 20
  start-page: 363
  year: 2020
  end-page: 374
  ident: 2023.07.09.548285v1.137
  article-title: The trinity of COVID-19: immunity, inflammation and intervention
  publication-title: Nat Rev Immunol
– volume: 106
  start-page: 1519
  year: 2020
  end-page: 1524
  ident: 2023.07.09.548285v1.35
  article-title: Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
  publication-title: Heart
– volume: 5
  year: 2014
  ident: 2023.07.09.548285v1.71
  article-title: Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses
  publication-title: J Pharmacogenomics Pharmacoproteomics
– volume: 369
  start-page: 1210
  year: 2020
  end-page: 1220
  ident: 2023.07.09.548285v1.6
  article-title: Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
  publication-title: Science
– volume: 11
  start-page: 3793
  year: 2020
  ident: 2023.07.09.548285v1.115
  article-title: Strategies to enable large-scale proteomics for reproducible research
  publication-title: Nat Commun
– volume: 182
  start-page: 59
  year: 2020
  end-page: 72
  ident: 2023.07.09.548285v1.132
  article-title: Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
  publication-title: Cell
– volume: 126
  start-page: 1671
  year: 2020b
  end-page: 1681
  ident: 2023.07.09.548285v1.159
  article-title: Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
  publication-title: Circ Res
– volume: 43
  start-page: 1781
  year: 2017a
  end-page: 1792
  ident: 2023.07.09.548285v1.4
  article-title: Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM)
  publication-title: Intensive Care Med
– volume: 217
  year: 2020
  ident: 2023.07.09.548285v1.146
  article-title: SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology
  publication-title: J Exp Med
– volume: 591
  start-page: 124
  year: 2021
  end-page: 130
  ident: 2023.07.09.548285v1.24
  article-title: Global absence and targeting of protective immune states in severe COVID-19
  publication-title: Nature
– volume: 222
  start-page: 734
  year: 2020
  end-page: 745
  ident: 2023.07.09.548285v1.154
  article-title: Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation
  publication-title: J Infect Dis
– volume: 22
  start-page: 32
  year: 2021
  end-page: 40
  ident: 2023.07.09.548285v1.39
  article-title: Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
  publication-title: Nat Immunol
– volume: 19
  start-page: 1110
  year: 2013
  end-page: 1120
  ident: 2023.07.09.548285v1.104
  article-title: Angiotensin II, NADPH oxidase, and redox signaling in the vasculature
  publication-title: Antioxid Redox Signal
– volume: 11
  start-page: 3810
  year: 2020
  ident: 2023.07.09.548285v1.80
  article-title: Activation and evasion of type I interferon responses by SARS-CoV-2
  publication-title: Nat Commun
– volume: 46
  start-page: 586
  year: 2020a
  end-page: 590
  ident: 2023.07.09.548285v1.158
  article-title: Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
  publication-title: Intensive Care Med
– volume: 14
  start-page: 68
  year: 2019
  end-page: 85
  ident: 2023.07.09.548285v1.59
  article-title: Single-pot, solid-phase-enhanced sample preparation for proteomics experiments
  publication-title: Nat Protoc
– volume: 8
  start-page: e80747
  year: 2013
  ident: 2023.07.09.548285v1.109
  article-title: PaGenBase: a pattern gene database for the global and dynamic understanding of gene function
  publication-title: PLoS One
– volume: 53
  start-page: 487
  year: 2020
  end-page: 495
  ident: 2023.07.09.548285v1.18
  article-title: Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions
  publication-title: Immunity
– volume: 369
  start-page: 718
  year: 2020
  end-page: 724
  ident: 2023.07.09.548285v1.49
  article-title: Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
  publication-title: Science
– volume: 71
  start-page: 2121
  year: 2020
  end-page: 2128
  ident: 2023.07.09.548285v1.62
  article-title: Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)-Related Outcomes in Korea: A Nationwide Population-based Cohort Study
  publication-title: Clin Infect Dis
– volume: 71
  start-page: 329
  year: 2015
  end-page: 340
  ident: 2023.07.09.548285v1.88
  article-title: Orosomucoid, an acute response protein with multiple modulating activities
  publication-title: J Physiol Biochem
– volume: 147
  start-page: 81
  year: 2021
  end-page: 91
  ident: 2023.07.09.548285v1.121
  article-title: Compartmental immunophenotyping in COVID-19 ARDS: A case series
  publication-title: J Allergy Clin Immunol
– volume: 49
  start-page: D394
  year: 2021
  end-page: D403
  ident: 2023.07.09.548285v1.97
  article-title: PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API
  publication-title: Nucleic Acids Res
– volume: 472
  start-page: 481
  year: 2011
  end-page: 485
  ident: 2023.07.09.548285v1.130
  article-title: A diverse range of gene products are effectors of the type I interferon antiviral response
  publication-title: Nature
– volume: 21
  start-page: 169
  year: 2020
  ident: 2023.07.09.548285v1.155
  article-title: Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19
  publication-title: Respir Res
– volume: 395
  start-page: 1033
  year: 2020
  end-page: 1034
  ident: 2023.07.09.548285v1.94
  article-title: COVID-19: consider cytokine storm syndromes and immunosuppression
  publication-title: Lancet
– volume: 45
  start-page: 2078
  year: 2017b
  end-page: 2088
  ident: 2023.07.09.548285v1.5
  article-title: Guidelines for the Diagnosis and Management of Critical Illness-Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017
  publication-title: Crit Care Med
– volume: 23
  start-page: 154
  year: 2015
  end-page: 163
  ident: 2023.07.09.548285v1.50
  article-title: Mx GTPases: dynamin-like antiviral machines of innate immunity
  publication-title: Trends Microbiol
– volume: 63
  start-page: 364
  year: 2020b
  end-page: 374
  ident: 2023.07.09.548285v1.85
  article-title: Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
  publication-title: Sci China Life Sci
– volume: 12
  start-page: 773
  year: 2021
  ident: 2023.07.09.548285v1.30
  article-title: Low level of plasminogen increases risk for mortality in COVID-19 patients
  publication-title: Cell Death Dis
– volume: 23
  start-page: 1314
  year: 2021
  end-page: 1328
  ident: 2023.07.09.548285v1.149
  article-title: A single-cell transcriptomic landscape of the lungs of patients with COVID-19
  publication-title: Nat Cell Biol
– volume: 52
  start-page: 217
  year: 2020
  end-page: 221
  ident: 2023.07.09.548285v1.42
  article-title: Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease
  publication-title: Physiol Genomics
– volume: 382
  start-page: 2368
  year: 2020
  end-page: 2371
  ident: 2023.07.09.548285v1.123
  article-title: The Untold Toll - The Pandemic’s Effects on Patients without Covid-19
  publication-title: N Engl J Med
– volume: 36
  start-page: 1230
  year: 2021
  end-page: 1235
  ident: 2023.07.09.548285v1.31
  article-title: Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?
  publication-title: J Enzyme Inhib Med Chem
– volume: 21
  start-page: e51252
  year: 2020
  ident: 2023.07.09.548285v1.26
  article-title: SARS-CoV-2 evades immune detection in alveolar macrophages
  publication-title: EMBO Rep
– volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  ident: 2023.07.09.548285v1.58
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
– volume: 189
  start-page: 2689
  year: 2012
  end-page: 2695
  ident: 2023.07.09.548285v1.63
  article-title: Neutrophil extracellular traps: double-edged swords of innate immunity
  publication-title: J Immunol
– volume: 8
  start-page: e82966
  year: 2013
  ident: 2023.07.09.548285v1.21
  article-title: Vitamin A deficiency impairs adaptive B and T cell responses to a prototype monovalent attenuated human rotavirus vaccine and virulent human rotavirus challenge in a gnotobiotic piglet model
  publication-title: PLoS One
– volume: 6
  start-page: 65
  year: 2020
  ident: 2023.07.09.548285v1.100
  article-title: SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2
  publication-title: Cell Discov
– volume: 7
  start-page: eabm5505
  year: 2022
  ident: 2023.07.09.548285v1.108
  article-title: Innate immunological pathways in COVID-19 pathogenesis
  publication-title: Sci Immunol
– volume: 22
  year: 2021
  ident: 2023.07.09.548285v1.25
  article-title: Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
  publication-title: Int J Mol Sci
– volume: 384
  start-page: 693
  year: 2021
  end-page: 704
  ident: 2023.07.09.548285v1.46
  article-title: Dexamethasone in Hospitalized Patients with Covid-19
  publication-title: N Engl J Med
– volume: 1866
  start-page: 165878
  year: 2020
  ident: 2023.07.09.548285v1.103
  article-title: Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
  publication-title: Biochim Biophys Acta Mol Basis Dis
– volume: 13
  start-page: e0200004
  year: 2018
  ident: 2023.07.09.548285v1.122
  article-title: Activation of Nrf2 in the liver is associated with stress resistance mediated by suppression of the growth hormone-regulated STAT5b transcription factor
  publication-title: PLoS One
– volume: 68
  start-page: 251
  year: 2020
  end-page: 252
  ident: 2023.07.09.548285v1.107
  article-title: COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications
  publication-title: Endocrine
– volume: 324
  start-page: 1330
  year: 2020
  end-page: 1341
  ident: 2023.07.09.548285v1.47
  article-title: Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis
  publication-title: JAMA
– volume: 11
  start-page: 875
  year: 2005
  end-page: 879
  ident: 2023.07.09.548285v1.72
  article-title: A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
  publication-title: Nat Med
– volume: 136
  start-page: 1317
  year: 2020
  end-page: 1329
  ident: 2023.07.09.548285v1.90
  article-title: Platelet gene expression and function in patients with COVID-19
  publication-title: Blood
– volume: 6
  start-page: 216
  year: 2021
  ident: 2023.07.09.548285v1.81
  article-title: Sera proteomic features of active and recovered COVID-19 patients: potential diagnostic and prognostic biomarkers
  publication-title: Signal Transduct Target Ther
– volume: 47
  start-page: 1765
  year: 2020
  end-page: 1767
  ident: 2023.07.09.548285v1.142
  article-title: A role for retinoids in the treatment of COVID-19?
  publication-title: Clin Exp Pharmacol Physiol
– volume: 24
  start-page: 290
  year: 2020
  ident: 2023.07.09.548285v1.152
  article-title: Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients
  publication-title: Crit Care
– volume: 7
  start-page: e05877
  year: 2021
  ident: 2023.07.09.548285v1.52
  article-title: Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis
  publication-title: Heliyon
– volume: 6
  start-page: 20200075
  year: 2020
  ident: 2023.07.09.548285v1.74
  article-title: A case of adrenal infarction in a patient with COVID 19 infection
  publication-title: BJR Case Rep
– volume: 192
  start-page: 2953
  year: 2014
  end-page: 2958
  ident: 2023.07.09.548285v1.118
  article-title: Modulation of T cell and innate immune responses by retinoic Acid
  publication-title: J Immunol
– volume: 20
  start-page: 100134
  year: 2021
  ident: 2023.07.09.548285v1.145
  article-title: Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx
  publication-title: Mol Cell Proteomics
– volume: 136
  start-page: 1169
  year: 2020
  end-page: 1179
  ident: 2023.07.09.548285v1.98
  article-title: Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
  publication-title: Blood
– volume: 7
  start-page: 11624
  year: 2016
  ident: 2023.07.09.548285v1.70
  article-title: Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
  publication-title: Nat Commun
– volume: 93
  start-page: 678
  year: 2021
  end-page: 680
  ident: 2023.07.09.548285v1.54
  article-title: Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7
  publication-title: J Med Virol
– volume: 11
  start-page: 22958
  year: 2021
  ident: 2023.07.09.548285v1.92
  article-title: Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome
  publication-title: Sci Rep
– volume: 87
  start-page: 110121
  year: 2021
  ident: 2023.07.09.548285v1.128
  article-title: A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder
  publication-title: Cell Signal
– volume: 11
  start-page: 536
  year: 2011
  end-page: 542
  ident: 2023.07.09.548285v1.22
  article-title: FOXP3 and RORgammat: transcriptional regulation of Treg and Th17
  publication-title: Int Immunopharmacol
SSID ssj0002961374
Score 1.6954783
SecondaryResourceType preprint
Snippet An aberrant innate immune system caused by the beta coronavirus SARS-CoV-2 is a characteristic manifestation of severe coronavirus disease 2019 (COVID-19)....
SourceID biorxiv
SourceType Open Access Repository
SubjectTerms Immunology
Title Proteome profiling of nasopharynx reveals pathophysiological signature of COVID-19 disease severity
URI https://www.biorxiv.org/content/10.1101/2023.07.09.548285
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NS8MwFA-6IXjzE7-J4DUjTdO1uTo3puAcMmW3kpemsIPtKFO2_9732io7ePDY0lB4ycvvffH7MXaHqJxpiEFkuKdC504JsLnCLIXY0_MYgnqa8HnSH7_pp3k035L6orFKWJTVevFV9_FpYBtv38a5ZUC5elizbZoextoqiXZZF4-UJp8czXu_5RVlEKdi3fYx_1yJEW_7py1EGR2w7tQufXXIdnxxxPYaScjNMXNTIk4oPzxv1LQRWXiZ88KS3ICtNsWaE-kSHhpOYsJlXZn4ucA4TWPUTJ20ZvDy_vggAsPbJgxHEPSkVXfCZqPhbDAWrRCCgLgfCXABGG_yBHTfZmESaW3ReVymo8RbUNIawKQysoEE7bSzgXGAjz50SnkMSE5ZpygLf8a4RMwCQNsop3UmEwMmzI3GsAQzi1C5c3bb2iRdNmwXKdktlXEqTdrY7eIf31yyfXpHRdBAXrHOqvr014jeK7hh3fvhZPp6U-_XN6fMltk
linkProvider Cold Spring Harbor Laboratory Press
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV07T8MwELagFYKNp3hjJNZUjuM08VyoWmhLh4K6RT7HkTqQVKGg9t9zlwTEwMBoxVak8-O7l76PsTtE5VRBBF6Ke-qpzEoPTCYxSiH29CwCv-omHE-6gxf1OA_nTcLtvWmrhEVRrhefVR2fGrbx9a0vt_ApVg8qtk3dQV9bxmGH0tTbrE1EZ3Sq-_POT45FagSrSDXFzD-Xo9vb_O4XrPT3WXtqlq48YFsuP2Q7tS7k5ojZKbEnFG-O15LaCC-8yHhuSHPAlJt8zYl5CU8OJ0XhokpPfL9inFoyKrpOWtN7fh3ee77mTSWGIxI6Eqw7ZrP-w6w38Bo1BA-ibuiB9UE7ncWguiYN4lApgzfIpiqMnQEpjAaMLEPjC1BWWeNrCzh0gZXSoVdywlp5kbtTxgUCFwDaRlqlUhFr0EGmFfomGF4E0p6x28YmybKmvEjIbomIEqGT2m7n_5hzw3YHs_EoGQ0nTxdsj75TVtQXl6y1Kj_cFcL5Cq6rPfsCFKqaFg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3JTsMwELWgFYgbq9gxEtdEjuM08bmlallKDwX1FnkcR-JAUkUFtX_PTBJQDxw4Rtmk8fJm83uM3SEqZwpi8DIcU0_lVnpgcolRCrGn5zEEdTfh86Q3elUP82i-cRaG2irhvaxW7191HZ8atnH3bRa3CChWD2u2Te2jry2TyKc0tb_I8m3WxbmlSL5hOPd_8yxSI2DFqi1o_vkJdH3bX25Ay3Cfdadm4aoDtuWKQ7bTaEOuj5idEoNC-eF4I6uNEMPLnBeGdAdMtS5WnNiXcPZwUhUu6xTFz07GqS2jpuykd_ovb-OBF2jeVmM4oqEj0bpjNhvez_ojr1VE8CDuRR7YALTTeQKqZ7IwiZQyuIpspqLEGZDCaMDoMjKBAGWVNYG2gJcutFI69ExOWKcoC3fKuEDwAkDbSKtUJhINOsy1Qv8EQ4xQ2jN229okXTS0FynZLRVxKnTa2O38H8_csN3pYJg-jSePF2yPblNiNBCXrLOsPt0VIvoSrush-wZoeZse
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Proteome+profiling+of+nasopharynx+reveals+pathophysiological+signature+of+COVID-19+disease+severity&rft.jtitle=bioRxiv&rft.au=Ooi%2C+Amanda&rft.au=Esau%2C+Luke+E.&rft.au=Pugachev%2C+Artyom&rft.au=Groen%2C+Arnoud&rft.date=2023-07-10&rft.pub=Cold+Spring+Harbor+Laboratory&rft.eissn=2692-8205&rft_id=info:doi/10.1101%2F2023.07.09.548285&rft.externalDocID=2023.07.09.548285v1